SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
F
O R M 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of February 2010
STARLIMS
Technologies Ltd.
(Name of
Registrant)
32B Habarzel Street, Tel Aviv 69710,
Israel
(Address
of Principal Executive Office)
Indicate by check mark whether the
registrant files or will file annual reports under cover of Form 20-F or Form
40-F.
Form
20-F
x
Form 40-F
o
Indicate by check mark if the
registrant is submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(1):
o
Indicate by check mark if the
registrant is submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(7):
o
Indicate by check mark whether by
furnishing the information contained in this Form, the registrant is also
thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934.
Yes
o
No
x
If
"Yes" is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): 82- __________
STARLIMS
Technologies Ltd.
6-K
Items
1. Press
release: STARLIMS Announces Shareholder Approval of Acquisition by Abbott; dated
February 16, 2010
ITEM
1
STARLIMS
Announces Shareholder Approval of Acquisition by Abbott
HOLLYWOOD,
Fla., Feb. 16, 2010 -- STARLIMS Technologies Ltd. (Nasdaq:LIMS ), a leading
provider of laboratory information management systems (LIMS), today announced
that at its special meeting of shareholders held today, STARLIMS’s shareholders
approved the terms and conditions of the previously announced acquisition of
STARLIMS by Abbott (NYSE: ABT), the global health care company.
The
transaction is subject to customary closing conditions. Under Israeli
law, at least 30 days must elapse after the approval of the acquisition by the
shareholders of STARLIMS before the acquisition may become
effective. STARLIMS and Abbott expect to complete the transaction by
March 31, 2010.
About
STARLIMS
STARLIMS
Technologies Ltd. (Nasdaq:LIMS) is a leading provider of laboratory information
management systems (LIMS), with over 20 years of LIMS experience. The Company's
flagship product, STARLIMS®, improves the reliability of laboratory sampling
processes, supports compliance with domestic and international regulations and
industry standards, and provides comprehensive reporting, monitoring and
analysis capabilities. STARLIMS software is used for quality assurance and
control, testing and monitoring, and research and development in government,
manufacturing and life sciences organizations. With operations in the United
States, Canada, the United Kingdom, Israel and Hong Kong, the company serves
over 500 organizations in 40 countries. For more information, please see
http://www.starlims.com.
Safe
Harbor for Forward-Looking Statements
This
press release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking statements
involve known and unknown risks and uncertainties which could cause the actual
results, performance or achievements of the company to be materially different
from those which may be expressed or implied by such statements, including,
among others, changes in general economic and business conditions, changes in
demand for products and services, the timing and amount or cancellation of
orders, loss of market share and other risks detailed from time to time in
STARLIMS's filings from time to time with the Securities and Exchange
Commission. Such filings contain and identify these and other important factors
that could cause actual results to differ materially from those contained in our
projections or forward-looking statements. Shareholders and other readers are
cautioned not to place undue reliance on these forward-looking statements, which
speak only as of the date on which they are made. We undertake no obligation to
update publicly or revise any forward-looking statement.
SIGNATURE
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
STARLIMS
Technologies Ltd.
|
|
|
|
|
|
|
|
|
By:
|
/s/ Chaim
Friedman
|
|
|
|
|
Chaim
Friedman
|
|
|
|
|
Chief
Financial Officer
|
|
Date:
February 16, 2010